MedPath

Efficacy and safety of cidofovir for recurrent respiratory papillomatosis (3)

Not Applicable
Conditions
recurrent respiratory papillomatosis
Registration Number
JPRN-UMIN000020348
Lead Sponsor
Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression-free duration of recurrent respiratory papillomatosis based on Derkay's severity score
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath